Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis

Overview of attention for article published in Frontiers in endocrinology, February 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 1 X post from an account with 94 followers.

Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis https://t.co/pHJsJE75Cw

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.